General Information of Drug Off-Target (DOT) (ID: OT5Z9CUA)

DOT Name Seizure 6-like protein (SEZ6L)
Gene Name SEZ6L
Related Disease
Lung neoplasm ( )
Neoplasm ( )
Non-small-cell lung cancer ( )
Small-cell lung cancer ( )
Autism spectrum disorder ( )
Bipolar disorder ( )
Lung cancer ( )
Lung carcinoma ( )
Mental disorder ( )
Plasma cell myeloma ( )
Acute myelogenous leukaemia ( )
Niemann-Pick disease type C ( )
UniProt ID
SE6L1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
2YRA
Pfam ID
PF00431 ; PF00084
Sequence
MPAARPPAAGLRGISLFLALLLGSPAAALERDALPEGDASPLGPYLLPSGAPERGSPGKE
HPEERVVTAPPSSSQSAEVLGELVLDGTAPSAHHDIPALSPLLPEEARPKHALPPKKKLP
SLKQVNSARKQLRPKATSAATVQRAGSQPASQGLDLLSSSTEKPGPPGDPDPIVASEEAS
EVPLWLDRKESAVPTTPAPLQISPFTSQPYVAHTLPQRPEPGEPGPDMAQEAPQEDTSPM
ALMDKGENELTGSASEESQETTTSTIITTTVITTEQAPALCSVSFSNPEGYIDSSDYPLL
PLNNFLECTYNVTVYTGYGVELQVKSVNLSDGELLSIRGVDGPTLTVLANQTLLVEGQVI
RSPTNTISVYFRTFQDDGLGTFQLHYQAFMLSCNFPRRPDSGDVTVMDLHSGGVAHFHCH
LGYELQGAKMLTCINASKPHWSSQEPICSAPCGGAVHNATIGRVLSPSYPENTNGSQFCI
WTIEAPEGQKLHLHFERLLLHDKDRMTVHSGQTNKSALLYDSLQTESVPFEGLLSEGNTI
RIEFTSDQARAASTFNIRFEAFEKGHCYEPYIQNGNFTTSDPTYNIGTIVEFTCDPGHSL
EQGPAIIECINVRDPYWNDTEPLCRAMCGGELSAVAGVVLSPNWPEPYVEGEDCIWKIHV
GEEKRIFLDIQFLNLSNSDILTIYDGDEVMPHILGQYLGNSGPQKLYSSTPDLTIQFHSD
PAGLIFGKGQGFIMNYIEVSRNDSCSDLPEIQNGWKTTSHTELVRGARITYQCDPGYDIV
GSDTLTCQWDLSWSSDPPFCEKIMYCTDPGEVDHSTRLISDPVLLVGTTIQYTCNPGFVL
EGSSLLTCYSRETGTPIWTSRLPHCVSEESLACDNPGLPENGYQILYKRLYLPGESLTFM
CYEGFELMGEVTIRCILGQPSHWNGPLPVCKVNQDSFEHALEVAEAAAETSLEGGNMALA
IFIPVLIISLLLGGAYIYITRCRYYSNLRLPLMYSHPYSQITVETEFDNPIYETGETREY
EVSI
Function May contribute to specialized endoplasmic reticulum functions in neurons.
Tissue Specificity Widely expressed, including adult and fetal brains and lungs. Not expressed in all lung cancer cell lines.

Molecular Interaction Atlas (MIA) of This DOT

12 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Lung neoplasm DISVARNB Definitive Genetic Variation [1]
Neoplasm DISZKGEW Definitive Altered Expression [1]
Non-small-cell lung cancer DIS5Y6R9 Definitive Altered Expression [1]
Small-cell lung cancer DISK3LZD Definitive Altered Expression [1]
Autism spectrum disorder DISXK8NV Strong Biomarker [2]
Bipolar disorder DISAM7J2 Strong Biomarker [3]
Lung cancer DISCM4YA Strong Genetic Variation [4]
Lung carcinoma DISTR26C Strong Genetic Variation [4]
Mental disorder DIS3J5R8 Strong Biomarker [5]
Plasma cell myeloma DIS0DFZ0 Strong Biomarker [6]
Acute myelogenous leukaemia DISCSPTN moderate Genetic Variation [7]
Niemann-Pick disease type C DIS492ZO moderate Biomarker [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
6 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Seizure 6-like protein (SEZ6L). [9]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Seizure 6-like protein (SEZ6L). [10]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Seizure 6-like protein (SEZ6L). [11]
Vorinostat DMWMPD4 Approved Vorinostat decreases the expression of Seizure 6-like protein (SEZ6L). [12]
Triclosan DMZUR4N Approved Triclosan decreases the expression of Seizure 6-like protein (SEZ6L). [13]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of Seizure 6-like protein (SEZ6L). [15]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Seizure 6-like protein (SEZ6L). [14]
------------------------------------------------------------------------------------

References

1 Seizure 6-like (SEZ6L) gene and risk for lung cancer.Cancer Res. 2007 Sep 1;67(17):8406-11. doi: 10.1158/0008-5472.CAN-06-4784.
2 Whole exome sequencing in extended families with autism spectrum disorder implicates four candidate genes.Hum Genet. 2015 Oct;134(10):1055-68. doi: 10.1007/s00439-015-1585-y. Epub 2015 Jul 24.
3 Polymorphisms in seizure 6-like gene are associated with bipolar disorder I: evidence of gene gender interaction.J Affect Disord. 2013 Feb 15;145(1):95-9. doi: 10.1016/j.jad.2012.07.017. Epub 2012 Aug 22.
4 Incorporation of a genetic factor into an epidemiologic model for prediction of individual risk of lung cancer: the Liverpool Lung Project.Cancer Prev Res (Phila). 2010 May;3(5):664-9. doi: 10.1158/1940-6207.CAPR-09-0141. Epub 2010 Apr 27.
5 Lack of Sez6 Family Proteins Impairs Motor Functions, Short-Term Memory, and Cognitive Flexibility and Alters Dendritic Spine Properties.Cereb Cortex. 2020 Apr 14;30(4):2167-2184. doi: 10.1093/cercor/bhz230.
6 Identification of unbalanced genome copy number abnormalities in patients with multiple myeloma by single-nucleotide polymorphism genotyping microarray analysis.Int J Hematol. 2012 Oct;96(4):492-500. doi: 10.1007/s12185-012-1171-1. Epub 2012 Sep 13.
7 Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.Oncotarget. 2017 Jan 31;8(5):7891-7899. doi: 10.18632/oncotarget.13631.
8 BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains.PLoS One. 2018 Jul 6;13(7):e0200344. doi: 10.1371/journal.pone.0200344. eCollection 2018.
9 Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
10 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
11 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
12 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
13 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
14 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
15 Cellular reactions to long-term volatile organic compound (VOC) exposures. Sci Rep. 2016 Dec 1;6:37842. doi: 10.1038/srep37842.